Sabby Management’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,422
| Closed | -$508K | – | 103 |
|
|
2021
Q2 | $508K | Buy |
1,422
+125
| +10% | +$44.7K | 0.07% | 59 |
|
|
2021
Q1 | $626K | Sell |
1,297
-366
| -22% | -$177K | 0.12% | 49 |
|
|
2020
Q4 | $1.04M | Buy |
+1,663
| New | +$1.04M | 0.2% | 20 |
|
|
2017
Q1 | – | Sell |
-108
| Closed | -$395K | – | 142 |
|
|
2016
Q4 | $395K | Buy |
+108
| New | +$395K | 0.02% | 100 |
|
|
2016
Q2 | – | Sell |
-24
| Closed | -$242K | – | 162 |
|
|
2016
Q1 | $242K | Sell |
24
-5
| -17% | -$50.4K | 0.01% | 146 |
|
|
2015
Q4 | $633K | Buy |
29
+16
| +123% | +$349K | 0.03% | 102 |
|
|
2015
Q3 | $751K | Sell |
13
-6
| -32% | -$347K | 0.03% | 130 |
|
|
2015
Q2 | $1.64M | Sell |
19
-3
| -14% | -$259K | 0.06% | 70 |
|
|
2015
Q1 | $2.02M | Buy |
22
+1
| +5% | +$91.6K | 0.08% | 55 |
|
|
2014
Q4 | $1.92K | Sell |
21
-3
| -13% | -$274 | 0.06% | 53 |
|
|
2014
Q3 | $1.66K | Buy |
+24
| New | +$1.66K | 0.06% | 47 |
|